Chong Kun Dang Pharmaceutical Corp. (KRX: 185750)

Chong Kun Dang Pharmaceutical Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	205,071	219,646	117,417	131,813	123,659	76,923
Short-Term Investments	131,011	143,095	8,871	-	4,869	14,448
Trading Asset Securities	3,307	2,324	29,573	55,520	33,328	1,003
Cash & Short-Term Investments	339,389	365,065	155,861	187,333	161,855	92,373
Cash Growth	82.46%	134.22%	-16.80%	15.74%	75.22%	101.04%
Accounts Receivable	268,186	269,632	248,409	203,598	183,288	174,011
Other Receivables	37,537	40,508	31,339	24,697	36,225	23,996
Receivables	305,722	310,140	279,749	228,295	219,514	198,007
Inventory	337,368	261,432	270,081	224,723	185,565	148,454
Prepaid Expenses	2,698	2,141	2,012	2,127	1,939	2,335
Other Current Assets	9,761	7,793	5,912	24,670	31,241	29,967
Total Current Assets	994,939	946,572	713,615	667,147	600,114	471,135
Property, Plant & Equipment	317,275	319,787	310,697	298,910	274,650	263,086
Long-Term Investments	43,171	41,144	44,010	33,373	26,564	25,092
Other Intangible Assets	65,389	52,062	26,953	20,806	19,033	15,915
Long-Term Deferred Tax Assets	18,293	14,213	6,209	2,350	-	-
Long-Term Deferred Charges	921.61	464.72	-	-	-	-
Other Long-Term Assets	28,061	28,186	23,399	24,114	25,972	26,123
Total Assets	1,468,047	1,402,428	1,124,883	1,046,700	946,333	801,352
Accounts Payable	231,379	183,939	145,436	129,327	144,120	101,969
Accrued Expenses	8,936	16,323	11,060	10,243	9,169	12,824
Short-Term Debt	90,997	90,959	96,270	74,656	73,049	52,312
Current Portion of Long-Term Debt	81,764	90,740	27,264	24,681	2,944	37,235
Current Portion of Leases	2,990	3,068	911.36	2,755	2,639	2,666
Current Income Taxes Payable	15,469	43,938	20,211	13,127	24,567	12,601
Current Unearned Revenue	36.79	20.08	5.46	5.83	9.2	1,115
Other Current Liabilities	69,566	82,478	73,054	65,435	64,124	56,346
Total Current Liabilities	501,137	511,466	374,213	320,230	320,621	277,069
Long-Term Debt	36,467	30,000	110,510	134,246	54,986	21,496
Long-Term Leases	3,867	4,997	782.86	715.88	2,523	4,349
Long-Term Deferred Tax Liabilities	-	-	-	-	1,631	924.02
Other Long-Term Liabilities	51,215	39,308	18,002	16,244	9,972	9,505
Total Liabilities	593,006	586,793	503,594	480,890	394,740	326,399
Common Stock	32,936	31,421	29,970	28,565	27,214	25,926
Additional Paid-In Capital	261,969	263,484	257,685	264,617	267,755	268,980
Retained Earnings	643,773	577,002	376,371	302,107	272,194	189,029
Treasury Stock	-58,041	-48,143	-34,666	-22,435	-10,584	-7,777
Comprensive Income & Other	-8,278	-8,070	-6,967	-6,843	-5,152	-2,637
Total Common Equity	872,359	815,694	622,393	566,010	551,427	473,520
Minority Interest	2,682	-59.33	-1,104	-200.34	166.02	1,433
Shareholders' Equity	875,041	815,635	621,289	565,810	551,593	474,953
Total Liabilities & Equity	1,468,047	1,402,428	1,124,883	1,046,700	946,333	801,352
Total Debt	216,084	219,764	235,738	237,054	136,141	118,058
Net Cash (Debt)	123,305	145,301	-79,877	-49,721	25,714	-25,685
Net Cash Per Share	9713.66	11420.67	-6230.36	-3809.65	1955.77	-1952.37
Filing Date Shares Outstanding	12.63	12.73	12.19	12.39	12.51	12.53
Total Common Shares Outstanding	12.63	12.73	12.8	13.01	13.14	13.16
Working Capital	493,802	435,106	339,402	346,917	279,493	194,066
Book Value Per Share	69074.43	64101.34	48630.53	43504.72	41973.35	35993.25
Tangible Book Value	806,971	763,632	595,440	545,204	532,394	457,605
Tangible Book Value Per Share	63896.88	60010.01	46524.56	41905.57	40524.63	34783.52
Land	111,779	111,145	116,028	108,235	106,346	106,114
Buildings	207,778	206,005	191,667	183,170	163,777	159,827
Machinery	297,263	292,292	274,583	252,066	226,051	202,843
Construction In Progress	24,999	21,716	19,946	19,901	20,029	16,976

Source: S&P Capital IQ. Standard template. Financial Sources.